Sarcoma, Ewing's

8 registered clinical trials studyying Sarcoma, Ewing's.

Status	Trial	Sponsor	Phase
Completed	Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With NCT01962103	Celgene	Phase 1 / Phase 2
Completed	Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment NCT00824083	University Hospital Muenster	—
Terminated	A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ew NCT00617890	Merck Sharp & Dohme LLC	Phase 2
Completed	A Study of Pemetrexed in Children With Recurrent Cancer NCT00520936	Eli Lilly and Company	Phase 2
Completed	Trial of Dasatinib in Advanced Sarcomas NCT00464620	Sarcoma Alliance for Research through Collaboration	Phase 2
Completed	Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors NCT00474760	Pfizer	Phase 1
Active Not Recruiting	Radiation Therapy to Treat Musculoskeletal Tumors NCT00186992	St. Jude Children's Research Hospital	Phase 2
Completed	A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectoderm NCT00001209	National Cancer Institute (NCI)	Phase 1